SHPH
NASDAQShuttle Pharmaceuticals Holdings Inc.
News25/Ratings0
News · 26 weeks290%
2025-10-262026-04-19
Mix1390d
- SEC Filings12(92%)
- Offering1(8%)
Latest news
25 items- SECSEC Form DEF 14A filed by Shuttle Pharmaceuticals Holdings Inc.DEF 14A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form PRE 14A filed by Shuttle Pharmaceuticals Holdings Inc.PRE 14A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 10-K filed by Shuttle Pharmaceuticals Holdings Inc.10-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRE.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public OfferingNEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), a leading investment banking and financial advisory firm, today announced that it acted as the exclusive placement agent in connection with a $3.5 million public offering by Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharmaceuticals" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early-stage drug development. Shuttle Pharmaceuticals entered into a securities purchase agreement with investors for the issuance and sale of 2,238,800 shares of common stock and pre-funded warrants to purchase 4,761,200 shares of common s
- SECSEC Form 8-K filed by Shuttle Pharmaceuticals Holdings Inc.8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc.424B3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form EFFECT filed by Shuttle Pharmaceuticals Holdings Inc.EFFECT - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECAmendment: SEC Form S-1/A filed by Shuttle Pharmaceuticals Holdings Inc.S-1/A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form S-1 filed by Shuttle Pharmaceuticals Holdings Inc.S-1 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc.424B3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form EFFECT filed by Shuttle Pharmaceuticals Holdings Inc.EFFECT - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- INSIDERSEC Form 3 filed by new insider Liang Yuying3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Issuer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECAmendment: SEC Form S-1/A filed by Shuttle Pharmaceuticals Holdings Inc.S-1/A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRShuttle Pharmaceuticals Acquires AI Health PlatformRockville, Maryland--(Newsfile Corp. - November 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle" or the "Company") today announced that it has closed the acquisition of the assets and liabilities of 1542770 B.C. Ltd. d/b/a Molecule.ai ("Molecule"), a Canadian artificial intelligence company specializing in molecular discovery and drug development technologies.Under the terms of the agreement, 1563868 B.C. Ltd., a wholly owned subsidiary of Shuttle, acquired substantially all of Molecule's assets and liabilities for a total purchase price of $8 million, payable in a combination of cash and shares of Shuttle common stock, plus an additional contingent $2 million, pay
- SECSEC Form S-1 filed by Shuttle Pharmaceuticals Holdings Inc.S-1 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 8-K filed by Shuttle Pharmaceuticals Holdings Inc.8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 10-Q filed by Shuttle Pharmaceuticals Holdings Inc.10-Q - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)